| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
2e-14 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-07 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-07 |
| mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.77 |
3e-07 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-06 |